Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Nippon Shinyaku to market and distribute DepoCyt in Japan

July 4, 2001

Gene and cell cycle effects elucidated for NB-1011

July 4, 2001

SafeScience to create joint venture with Elan for phase II anticancer agent

July 3, 2001

Additional beneficial effects emerge for SERM Sch-57068 (EM-652) in preclinical studies

July 3, 2001

ImClone Systems begins fast track approval process for colorectal cancer agent

July 3, 2001

Liver-targeted complexes of cisplatin and bile acids designed by Spanish group

July 3, 2001

FDA grants fast track designation for irofulven in pancreatic cancer

July 2, 2001

Mode of action of Oxigene's CA4P supported by preclinical data

July 2, 2001

Matrix commences new phase II IntraDose study for primary liver cancer

July 2, 2001

TLK-286 enters phase II trial for non-small cell lung cancer

July 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...